ID   Faraz-ICR
AC   CVCL_IU69
DR   Wikidata; Q54833251
RX   PubMed=28215484;
RX   PubMed=28719245;
CC   Population: Iranian.
CC   Doubling time: 35 hours (PubMed=28215484).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
DI   NCIt; C7977; Pancreatic acinar cell carcinoma
DI   ORDO; Orphanet_424046; Acinar cell carcinoma of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
RX   PubMed=28215484; DOI=10.1016/j.pan.2017.02.003;
RA   Rezaei M., Hosseini A., Nikeghbalian S., Ghaderi A.;
RT   "Establishment and characterization of a new human acinar cell
RT   carcinoma cell line, Faraz-ICR, from pancreas.";
RL   Pancreatology 17:303-309(2017).
//
RX   PubMed=28719245; DOI=10.1089/mab.2017.0013;
RA   Rezaei M., Ghaderi A.;
RT   "Production of a mouse monoclonal antibody against mortalin by whole
RT   cell immunization.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 36:169-175(2017).
//